Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
1 report, 1 independent
Updated Sep 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Cantor Fitzgerald and other analyst firms issued ratings on Amgen stock, which is listed on the Nasdaq exchange.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Amgen
American multinational biopharmaceutical company
-
Cantor Fitzgerald
American financial services company
-
Nasdaq
American fully electronic stock exchange
Related events
- Amgen Inc. trades on the NASDAQ stock exchange.
- The market is reacting to the news of Novartis' drug trial failures, specifically impacting Amgen's stock performance on the Nasdaq exchange.
- AMD stock trades on the Nasdaq exchange, with its price affected by analyst reports.
- AST SpaceMobile received analyst ratings and price targets while being listed on the Nasdaq stock exchange.
- Stock of Professional Diversity Network, Inc. traded on the Nasdaq exchange and was reported by MarketBeat.